NCT03926923 is a clinical trial of no intervention in Mother-Child Interaction, sponsored by University of Cologne.

Who is sponsoring NCT03926923?

NCT03926923 is sponsored by University of Cologne.

What drugs are being tested in NCT03926923?

Interventions in NCT03926923: no intervention.

What condition does NCT03926923 study?

NCT03926923 studies Mother-Child Interaction.

Is NCT03926923 still recruiting?

NCT03926923 is currently completed. Last updated 14 July 2023.

Last reviewed 2023-07-14 · How we verify

NCT03926923

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Analysis of Mother-child Interaction and Regulation of Candidate Genes of Stress Signaling Pathways in Mature Infants

Completed Last updated 14 July 2023

What this trial tests

trial testing no intervention in Mother-Child Interaction in 100 participants. Completed in 30 December 2020.

Timeline

18 July 2019

Primary endpoint
30 May 2020

30 December 2020

Quick facts

Lead sponsor	University of Cologne
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	18 July 2019
Primary completion	30 May 2020
Estimated completion	30 December 2020
Sites	1 location across Germany

Drugs / interventions tested

no intervention

Conditions studied

Mother-Child Interaction — all drugs for Mother-Child Interaction →

Sponsor

University of Cologne

Who can join

Adults 1 Day to 3 Days, any sex, with Mother-Child Interaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The planned study will investigate the quality of mother-child interaction at the age of 6 months as well as the expression and methylation of candidate genes of stress signaling pathway in mature infants. At best, mother and the healthy, term newborn are undisturbed after birth. This creates optimal conditions for the development of a good mother-child interaction. The results of the mother-child interaction and the molecular genetic investigations will be compared to the results of the randomized controlled delivery room skin-to-skin study (deisy, clinicaltrial.gov identifier: NCT 01959737). This study showed a significant difference in the mother-child interaction and expression of candidate genes in preterm infants with or without skin-to-skin contact after birth. The investigators hypothesize that the quality of mother-child interaction at the age of six months will be better in term newborns without postpartal separation of mother and child than in preterm infants with or without skin contact after birth. The second hypothesis is that there will be a difference in the expression and methylation of candidate genes of stress signaling pathway in these infants.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Does early skin-to-skin contact have a long-term effect on the emotional and behavioral development of very preterm infants?
Trautmann-Villalba P, Heine E, Kribs A, Mehler K. · · 2024 · PMID 39588126 · DOI 10.3389/fpsyg.2024.1484419

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

NCT07480057 — Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry · recruiting
NCT07253506 — Turkish Adaptation, Validity, and Reliability Study of the Patient Experience With Treatment and Self-Management Scale i · not yet recruiting
NCT07253519 — The Relationship Between Mood and Insomnia Severity and Caregiver Burden in Caregivers of Stroke · not yet recruiting
NCT07194096 — Stress Hyperglycemia Ratio and Postoperative Delirium · not yet recruiting
NCT07240337 — Botulinum Toxin Applications in Hemiplegic Patients · recruiting

Other University of Cologne trials

Trials by the same sponsor.

NCT07280585 — STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease · Phase 3 · recruiting
NCT06612515 — Vaccine-induced Immunity in Immunocompromised Patients · recruiting
NCT06781710 — Analysis of the Epidemiology, Clinical Presentation and Therapy as Well as Therapy-associated Risk of Demyelination Synd · recruiting
NCT05969431 — Hair Cortisol as Marker of Chronic Stress in Preterm and Term Fathers - Fathair-study · recruiting
NCT05876221 — Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03926923 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Cologne
Last refreshed: 14 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03926923.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing